Medtronic (MDT) Emerges as a Top Healthcare Stock Amid Business Revamp
Medtronic (MDT -0.68%) is currently trading at a historically high dividend yield of approximately 3%, presenting a compelling opportunity for investors. The medical device giant is navigating a turnaround, with its R&D pipeline gaining momentum after a period of stagnation. New surgical robots and cardiac ablation systems are now driving growth.
The company's strategic focus on higher-margin businesses further strengthens its position. A planned spinoff of its diabetes division—which carries lower profitability than its cardiovascular, medical surgical, and neuroscience units—is expected to be immediately accretive to earnings. Wall Street may be underestimating Medtronic's earnings potential as these initiatives take hold.